Therapeutic opportunities in the B7/CD28 family of ligands and receptors.

Abstract:

:The CD28 and B7 protein families are critical regulators of immune responses and, in the past few years, several new family members have been identified. Preclinical studies exploring the role of members of the CD28 and B7 families support the targeting of these pathways for new therapeutic approaches. Indeed, recent Phase I clinical studies using agonists and antagonists of the CD28/CTLA-4/B7 pathway have shown promise in inflammatory diseases and cancer.

journal_name

Curr Opin Pharmacol

authors

Carreno BM,Carter LL,Collins M

doi

10.1016/j.coph.2005.02.003

keywords:

subject

Has Abstract

pub_date

2005-08-01 00:00:00

pages

424-30

issue

4

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(05)00071-8

journal_volume

5

pub_type

杂志文章,评审
  • Menopause, atherosclerosis, and coronary artery disease.

    abstract::Women have coronary heart disease (CHD) later than men. This review describes studies of CHD risk factors or outcomes based on studies of premenopausal women followed through the menopause transition, and prospective cohort studies of younger or older women with CHD risk markers or disease outcomes in the context of t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.01.005

    authors: Barrett-Connor E

    更新日期:2013-04-01 00:00:00

  • Porous silicon advances in drug delivery and immunotherapy.

    abstract::Biomedical applications of porous silicon include drug delivery, imaging, diagnostics and immunotherapy. This review summarizes new silicon particle fabrication techniques, dynamics of cellular transport, advances in the multistage vector approach to drug delivery, and the use of porous silicon as immune adjuvants. Re...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.06.006

    authors: Savage DJ,Liu X,Curley SA,Ferrari M,Serda RE

    更新日期:2013-10-01 00:00:00

  • Thrombomodulation via CLEC-2 targeting.

    abstract::CLEC-2 is a C-type lectin-like molecule that has recently been identified as a receptor on the surface of platelets. Ligand binding by CLEC-2 promotes phosphorylation of a tyrosine in the cytoplasmic domain YXXL motif of CLEC-2 by Src kinases and further downstream signalling events trigger platelet activation and agg...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.11.001

    authors: O'Callaghan CA

    更新日期:2009-04-01 00:00:00

  • siRNA and the lung: research tool or therapeutic drug?

    abstract::Oligonucleotide-based therapeutics have been hailed as 'the next great wave of the biotechnology revolution' starting with antisense oligonucleotides (ASOs) nearly 20 years ago to RNA interference (RNAi) currently. Is RNAi just the latest research tool or does it have real potential as a therapeutic drug modality? As ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.04.005

    authors: de Fougerolles A,Novobrantseva T

    更新日期:2008-06-01 00:00:00

  • 3D intestinal organoids in metabolic research: virtual reality in a dish.

    abstract::The advent of near physiological organoid technology has produced a step change in our understanding of stem cells and has provided the research community with a powerful new cell based tool to model human physiology and disease. We review the pros and cons of intestinal organoid culture systems. The molecular and gen...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.003

    authors: Tsakmaki A,Fonseca Pedro P,Bewick GA

    更新日期:2017-12-01 00:00:00

  • Purinergic signalling in the lung: important in asthma and COPD?

    abstract::During the past decade, evidence has accumulated for the involvement of purines and purine receptors in the pathogenesis and pathophysiology of asthma and chronic obstructive pulmonary diseases. In particular, the indirect bronchospasmic and inflammatory actions of purines via the activation and degranulation of mast ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.01.010

    authors: Adriaensen D,Timmermans JP

    更新日期:2004-06-01 00:00:00

  • Antibody therapy for rheumatoid arthritis.

    abstract::High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to protect joints from st...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00032-8

    authors: Taylor PC

    更新日期:2003-06-01 00:00:00

  • PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

    abstract::Among the methods based on molecular imaging, the measure of the tracer uptake variation between a baseline and follow-up scan with the SUV and [(18)F]FDG-PET/CT is a very powerful tool for assessing response to treatment in oncology. However, the development of new targeted therapeutics and tissue pharmacokinetic eva...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.07.016

    authors: Tomasi G,Rosso L

    更新日期:2012-10-01 00:00:00

  • GABAB receptor modulation-to B or not to be B a pro-cognitive medicine?

    abstract::Metabotropic GABAB receptors clearly modify cognitive performance in preclinical animal models, yet translation to treating human disease has been elusive. Compared to their ionotropic GABAA receptor counterpart GABAB receptors not only regulate postsynaptic excitability but also regulate diverse synaptic inputs by pr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.012

    authors: Serrats J,Cunningham MO,Davies CH

    更新日期:2017-08-01 00:00:00

  • Antiviral therapeutics for the treatment of Ebola virus infection.

    abstract::There have been significant developments in Ebola virus therapeutics. While the efficacy of several products was evaluated in the recent West Africa outbreak, a licensed treatment for EBOV disease remains elusive. Factors that negatively impacted the execution of clinical trials included an overall lack of world readi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.08.016

    authors: Cardile AP,Downey LG,Wiseman PD,Warren TK,Bavari S

    更新日期:2016-10-01 00:00:00

  • SIRT1 - a metabolic sensor that controls blood vessel growth.

    abstract::Blood vessels deliver nutrients and oxygen to cells and tissues in the body. When blood supply is insufficient new vessels form to meet the metabolic tissue requirements. Several studies have examined the cellular and molecular principles of blood vessel formation, yet little is known about how vessels sense and integ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.01.001

    authors: Guarani V,Potente M

    更新日期:2010-04-01 00:00:00

  • Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome.

    abstract::Irritable bowel syndrome, which affects 5-10% of the population includes around 25% with predominantly diarrhoea (IBS-D). Several lines of evidence suggest an increase in mucosal 5-HT availability in IBS-D including a decrease in the serotonin transporter (SERT) which is also seen following acute diverticulitis. 5-HT(...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.02.005

    authors: Spiller RC

    更新日期:2011-02-01 00:00:00

  • Monoclonal antibodies as a strategy for pulmonary diseases.

    abstract::Monoclonal antibodies have been used successfully to elucidate the roles of putative mediators of pulmonary disease. In particular, clinical trials with monoclonal antibodies directed against interleukin-5, IgE or CD4 yielded results that were critical in dissecting the pathophysiology of asthma; but, more importantly...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00047-9

    authors: Torphy TJ,Li L,Griswold DE

    更新日期:2001-06-01 00:00:00

  • Clinical effectiveness of novel rosacea therapies.

    abstract::Rosacea is a common inflammatory skin disease that is difficult to manage because of the unknown etiology and due to its variable manifestations. These facts and the few new available treatment options make it difficult to select a really effective treatment. This review aims to assess the efficacy and safety of novel...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.12.001

    authors: Feaster B,Cline A,Feldman SR,Taylor S

    更新日期:2019-06-01 00:00:00

  • New developments in Toll-like receptor targeted therapeutics.

    abstract::Toll-like receptors (TLRs) play a crucial role in host defence and inflammation. Given that a significant amount of evidence implicates TLRs in the pathogenesis of immune diseases and cancer, and their activation occurs early in the inflammatory cascade, they are attractive targets for novel therapeutic agents. Potent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.06.002

    authors: Connolly DJ,O'Neill LA

    更新日期:2012-08-01 00:00:00

  • Contribution of heteromerization to G protein-coupled receptor function.

    abstract::G protein-coupled receptors (GPCRs) are a remarkably multifaceted family of transmembrane proteins that exert a variety of physiological effects. Although family A GPCRs are able to operate as monomers, there is increasing evidence that heteromerization represents a fundamental aspect of receptor function, trafficking...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.10.006

    authors: Gaitonde SA,González-Maeso J

    更新日期:2017-02-01 00:00:00

  • The study of airway primary afferent neuron excitability.

    abstract::The activation of airway afferent neurons initiates a variety of reflexes including cough and bronchoconstriction. Like somatic afferent neurons involved in inflammation-induced hyperalgesia, the excitability of airway afferent neurons is not fixed but, rather, can be increased by the action of a variety of mediators ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00147-9

    authors: Carr MJ,Ellis JL

    更新日期:2002-06-01 00:00:00

  • Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors.

    abstract::Recent advances in the development of potent and selective peptide and non-peptide ligands for peptidergic receptors are anticipated to help further unravel the roles of class I and II G-protein-coupled receptors in the pathogenesis of human diseases and to accelerate the clinical utility of small molecule peptidomime...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.06.003

    authors: Jones RM,Boatman PD,Semple G,Shin YJ,Tamura SY

    更新日期:2003-10-01 00:00:00

  • New pathways to control inflammatory responses in adipose tissue.

    abstract::Obesity is characterized by the presence of chronic inflammation in adipose tissue, particularly in the visceral compartment, that has been causally linked to development of obesity-associated comorbidities. This link can be either direct or indirect, through induction of insulin resistance. This review summarizes rec...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.04.008

    authors: Akasheh RT,Pang J,York JM,Fantuzzi G

    更新日期:2013-08-01 00:00:00

  • New therapeutics for osteoporosis.

    abstract::Two new approaches for the treatment of osteoporosis are summarized, each having arisen out of important new discoveries in bone biology. Odanacatib (ODN) inhibits the enzyme, cathepsin K, that is essential for the resorbing activity of osteoclasts. It is effective in preventing ovariectomy-induced bone loss in precli...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.03.004

    authors: Ng KW,Martin TJ

    更新日期:2014-06-01 00:00:00

  • Gene expression profiling in stroke: relevance of blood-brain interaction.

    abstract::Biomarker profiling is utilized to identify diagnostic and prognostic candidates for stroke. Clinical and preclinical biomarker data suggest altered circulating immune responses may illuminate the mechanisms of stroke recovery. However, the relationship between peripheral blood biomarker profile(s) and brain profiles ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.10.004

    authors: Asano S,Chantler PD,Barr TL

    更新日期:2016-02-01 00:00:00

  • Peptides as cancer vaccines.

    abstract::Cancer vaccines based on synthetic peptides are a safe, well-tolerated immunotherapy able to specifically stimulate tumor-reactive T cells. However, their clinical efficacy does not approach that achieved with other immunotherapies such as immune checkpoint blockade. Nevertheless, major advances have been made in sele...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.01.007

    authors: Calvo Tardón M,Allard M,Dutoit V,Dietrich PY,Walker PR

    更新日期:2019-08-01 00:00:00

  • Cholesterol and the development of clear-cell renal carcinoma.

    abstract::The majority of kidney cancers are clear-cell carcinomas (ccRCC), characterized by the accumulation of cholesterol, cholesterol esters, other neutral lipids and glycogen. Rather than being a passive bystander, the clear-cell phenotype is suggested to be a biomarker of deregulated cholesterol and lipid biosynthesis, wh...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.08.002

    authors: Drabkin HA,Gemmill RM

    更新日期:2012-12-01 00:00:00

  • Determinants of chemosensitivity in gastric cancer.

    abstract::Recent advances in the management of gastric cancer, especially in the arena of chemotherapy, are paving the way for optimization of treatment that maximizes effectiveness while minimizing toxicity. The expansion of the chemotherapeutic armamentarium has led to multiple combinations of cytotoxic agents. Unfortunately,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.05.002

    authors: Park DJ,Lenz HJ

    更新日期:2006-08-01 00:00:00

  • Promoting apoptosis in disease management: a panacea or Trojan horse?

    abstract::In our enthusiasm to advocate apoptosis as a therapeutic strategy for the management of disease we need to be mindful that the clearance of apoptotic cells is itself immunomodulatory and that it may not always be as benign or beneficial as we think. Indeed, the existence of free apoptotic cells in situ may potentially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.005

    authors: Brown SB,Vernon-Wilson EF

    更新日期:2005-08-01 00:00:00

  • Mechanism of action of general anaesthetics--new information from molecular pharmacology.

    abstract::Major progress in our understanding of the mechanisms of anaesthesia has been made during the past year. Several key advances in defining very specific sites of action on ligand-gated ion channels have been described. Furthermore, new techniques have become available for addressing the identification of binding sites ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00013-3

    authors: Thompson SA,Wafford K

    更新日期:2001-02-01 00:00:00

  • PDE inhibitors: a new approach to treat metabolic syndrome?

    abstract::About one third of people in the world suffer from metabolic syndrome (MetS), with symptoms such as hypertension and elevated blood cholesterol, and with increased risk of developing additional diseases such as diabetes mellitus and heart disease. The progression of this multifactorial pathology, which targets various...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.09.012

    authors: Lugnier C

    更新日期:2011-12-01 00:00:00

  • New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases.

    abstract::Chronic liver diseases with different etiologies represent a major public health issue worldwide. Liver fibrosis is the common feature of almost all chronic liver diseases and remains a key determinant of clinical prognosis. Over the last two decades, basic science studies have uncovered molecular mechanisms underlyin...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.006

    authors: Lemoinne S,Friedman SL

    更新日期:2019-12-01 00:00:00

  • Targeting CYP17: established and novel approaches in prostate cancer.

    abstract::There is a growing body of evidence that although medical or surgical castration blocks the generation of gonadal testosterone in prostate cancer, androgens originating from other sources may continue to drive androgen receptor (AR) signaling. Recent studies have demonstrated high intratumoral levels of androgens and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.06.004

    authors: Yap TA,Carden CP,Attard G,de Bono JS

    更新日期:2008-08-01 00:00:00

  • Understanding the pharmacology of stroke and multiple sclerosis through imaging.

    abstract::Stroke and multiple sclerosis (MS) illustrate how clinical imaging can facilitate early phase drug development and most effective medicine use in the clinic. Imaging has enhanced understanding of the dynamics of evolution of disease pathophysiology, better defining treatment targets. Imaging measures can enable strati...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.10.006

    authors: Matthews PM,Geraghty OC

    更新日期:2014-02-01 00:00:00